Get the Stockscreener App
1.235
1.23%
0.015
Pre-market:
1.29
0.055
+4.45%
Pmv Pharmaceuticals Inc stock is traded at $1.235, with a volume of 218.85K.
It is up +1.23% in the last 24 hours and up +3.78% over the past month.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
See More
Previous Close:
$1.22
Open:
$1.23
24h Volume:
218.85K
Relative Volume:
0.54
Market Cap:
$65.72M
Revenue:
-
Net Income/Loss:
$-51.47M
P/E Ratio:
-1.235
EPS:
-1
Net Cash Flow:
$-47.50M
1W Performance:
-1.20%
1M Performance:
+3.78%
6M Performance:
+2.92%
1Y Performance:
-19.81%
1-Day Range:
$1.22
$1.26
1-Week Range:
$1.20
$1.29
52-Week Range:
$0.81
$1.84
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Name
Pmv Pharmaceuticals Inc
Sector
Industry
Phone
(609) 642-6670
Address
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.235 | 64.92M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-08-24 | Upgrade | Oppenheimer | Perform → Outperform |
| May-13-24 | Initiated | Craig Hallum | Buy |
| Apr-12-24 | Initiated | Jefferies | Buy |
| Dec-27-23 | Initiated | Ladenburg Thalmann | Buy |
| Mar-02-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-22-21 | Upgrade | Goldman | Neutral → Buy |
| Aug-19-21 | Initiated | Oppenheimer | Perform |
| Aug-02-21 | Initiated | Guggenheim | Buy |
| Jul-29-21 | Initiated | H.C. Wainwright | Buy |
| Oct-20-20 | Initiated | BofA Securities | Buy |
| Oct-20-20 | Initiated | Cowen | Outperform |
| Oct-20-20 | Initiated | Evercore ISI | Outperform |
| Oct-20-20 | Initiated | Goldman | Neutral |
View All
Pmv Pharmaceuticals Inc Stock (PMVP) Latest News
Chart Analysts Warn of Resistance Near Sterling and Wilson Renewable Energy Limited PriceWeekly Market Snapshot & Small Entry Portfolio - bollywoodhelpline.com
Will Volume Confirm Reversal in Rama Steel Tubes LimitedMarket Profile Overview & Rapid Portfolio Gain - bollywoodhelpline.com
How strong is PMV Pharmaceuticals Inc. stock balance sheet2026 world cup usa national team final young talents set piece tactics odds analysis preview - ulpravda.ru
PMV Pharmaceuticals (NASDAQ:PMVP) Stock Price Up 2.5%Here's What Happened - MarketBeat
Vani Commercials Limited May Be Forming Higher Low — Chartwatchers AlertTechnology Stock Trends & Investment Timing Techniques - bollywoodhelpline.com
Sector Rotation Brings Swan Defence and Heavy Industries Limited Into FocusVolatility Trading Techniques & Capital Allocation Recommendations - bollywoodhelpline.com
How resilient is PMV Pharmaceuticals Inc stock in market downturnsRate Hike & Weekly High Conviction Trade Ideas - moha.gov.vn
Is KEI Industries Limited in Accumulation Phase NowMarket Sentiment Report & Get Free Expert Trading Recommendations - bollywoodhelpline.com
Growth Report: Will PMV Pharmaceuticals Inc stock rally after Fed decisions2025 Biggest Moves & Long-Term Safe Investment Ideas - moha.gov.vn
How PMV Pharmaceuticals Inc. stock compares to growth peersMarket Growth Summary & Weekly Return Optimization Plans - Улправда
Sunrise Efficient Marketing Limited (543515) Quarterly Results Are Out2025 Price Momentum & Free Expert Verified Stock Movement Alerts - Bollywood Helpline
How PMV Pharmaceuticals Inc. stock responds to policy changesTrade Performance Summary & Community Trade Idea Sharing - Улправда
Aug Levels: How PMV Pharmaceuticals Inc. stock compares to growth peersJuly 2025 News Drivers & Community Consensus Stock Picks - Улправда
Fundamentals Check: What is the fair value of PMV Pharmaceuticals Inc. stock nowTrade Performance Summary & Long-Term Growth Portfolio Plans - DonanımHaber
Is PMV Pharmaceuticals Inc. stock ready for breakoutJuly 2025 Selloffs & Weekly High Return Opportunities - DonanımHaber
Is PMV Pharmaceuticals Inc. stock vulnerable to regulatory risksPortfolio Value Summary & Technical Buy Zone Confirmations - DonanımHaber
Will PMV Pharmaceuticals Inc. stock split attract more investors2025 Buyback Activity & Consistent Return Investment Signals - Улправда
How PMV Pharmaceuticals Inc. stock reacts to Fed rate cutsJuly 2025 Highlights & Target Return Focused Picks - Улправда
Trend Report: How PMV Pharmaceuticals Inc. stock reacts to Fed rate cutsCEO Change & Intraday High Probability Setup Alerts - Улправда
Will PMV Pharmaceuticals Inc. stock rally after Fed decisionsJuly 2025 Intraday Action & Weekly Sector Rotation Insights - Улправда
Institutions don’t gamble. Every trade is backed by:Sector ETF Performance & Access Free Risk Analysis Before You Invest - Bollywood Helpline
The Left Shoulder and Head formed clearly.Price Momentum Alerts & Outstanding Investment Trading - Bollywood Helpline
PMV Pharmaceuticals Earnings Notes - Trefis
PMV Pharmaceuticals announces updated rezatapopt monotherapy interim data - MSN
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Down 1.7%Here's Why - MarketBeat
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Down 1.7% – Here’s Why - Defense World
Will PMV Pharmaceuticals Inc. stock continue upward momentumPortfolio Gains Report & Real-Time Sentiment Analysis - Newser
PMV Pharmaceuticals (NASDAQ:PMVP) versus Aurinia Pharmaceuticals (NASDAQ:AUPH) Financial Comparison - Defense World
Why PMV Pharmaceuticals Inc. stock is a must watch in 2025Trade Risk Summary & Safe Entry Zone Identification - newser.com
Why PMV Pharmaceuticals Inc. stock appeals to analysts2025 Retail Activity & Precise Swing Trade Entry Alerts - newser.com
Contrasting PMV Pharmaceuticals (NASDAQ:PMVP) & Kiora Pharmaceuticals (NASDAQ:KPRX) - Defense World
Is PMV Pharmaceuticals Inc. stock poised for growth2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
How rising interest rates impact PMV Pharmaceuticals Inc. stockPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
Will PMV Pharmaceuticals Inc. stock outperform Dow Jones index2025 Price Targets & Real-Time Price Movement Reports - newser.com
Will PMV Pharmaceuticals Inc. stock benefit from commodity pricesCEO Change & Growth Oriented Trading Recommendations - newser.com
Is PMV Pharmaceuticals Inc. stock safe for conservative investorsJuly 2025 Momentum & Free High Return Stock Watch Alerts - newser.com
Is PMV Pharmaceuticals Inc. building a consolidation base2025 Volatility Report & Stock Portfolio Risk Control - newser.com
Pmv Pharmaceuticals Inc Stock (PMVP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pmv Pharmaceuticals Inc Stock (PMVP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner |
Oct 23 '25 |
Sale |
1.52 |
1,000,000 |
1,520,000 |
4,975,291 |
28.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):